INVO Bioscience, Inc., a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell® medical device and the intravaginal culture procedure it enables, announced plans to open an INVO Center in Kansas City, Missouri.
April 14, 2022
· 4 min read